Sentynl Therapeutics, Inc.

0 followers


Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.

Industries

Headquarters

Employees

Links

Org chart

Matt Heck
Founder & CEO

Matt Heck

Collapse
Darren Pincus
Senior Vice President, Business Development
Grant Castor
Senior Vice President Commercial Strategy & Operations
Eileen Banaga
Vp, Regulatory Affairs And Quality
Michael Hercz
Senior Vice President, General Counsel & Chief Compliance Officer
Jennifer Reese
Senior Vice President & Head Of Medical Affairs
Mike Cvijanovich
Senior Director Of Rare Disease Marketing
Yvonne Breugelmans Mshrm
Director Of Human Resources And Payroll